Scleral lenses provide patients with many benefits and are an extremely useful adjunct in treating patients with ocular surface disease (OSD). Step three of the TFOS DEWS II report1 notes gas permeable scleral contact lenses (CLs) can be very beneficial to patients with moderate-to-severe dry eye di
This randomised, double-masked, placebo-controlled trial investigated the effects of quantum molecular resonance (QMR) on the signs and symptoms of dry eye disease (DED). QMR is a novel dry eye therapy involving the topical application of electrical currents in the frequency-specific range of 4-64MH
Inflammation plays a key role in triggering and propagating dry eye disease (DED) via the ‘vicious circle’1. In severe cases, topical anti-inflammatory therapy may be indicated, but managing a patient’s meibomian gland dysfunction can often be sufficient to resolve ocular surface inflammation withou
In February of 2021, a 42-year-old woman was referred to our ocular surface disease clinic with ongoing symptoms of dry eye following her SARSCoV2 (Covid) infection in late 2019, which she had contracted in Hong Kong and had made her quite unwell.
An optimum balance of hormones is required to maintain tear film integrity and ocular surface health. These hormones, particularly in women, can be responsible for the development of dry eye disease (DED), but interestingly can also be used in DED treatment.
After successfully navigating Auckland’s extended Covid lockdown in 2021, the Ocular Surface Laboratory (OSL) team was excited to begin its long-awaited clinical trial to evaluate a single thermal pulsation treatment delivered by a novel handheld device (Systane iLux, Alcon) relative to standard-of-
The Tear Film and Ocular Surface Society (TFOS) second Dry Eye Workshop (DEWS II) reports were published in 2017. These brought practitioners up to date on the evidence basis for dry eye disease (DED), including our current understanding of the pathophysiology, a consensus-refined definition and a m
Dry eye disease (DED) is a common condition with a global prevalence estimated at 11.6%1. While DED is often idiopathic, the 2017 Tear Film and Ocular Surface Society Dry Eye Workshop II (TFOS DEWS II) highlighted the importance of secondary risk factors associated with systemic diseases2. Systemic
According to the TFOS DEWS II Definition and Classification report, “Dry eye is a common multifactorial disease of the ocular surface, characterised by a loss of homeostasis of the tear film and accompanied by ocular symptoms in which tear film instability and hyperosmolarity, ocular surface inflamm
It started with dirty lashes! A keratoconic patient had tried something new and while they looked fabulous, on closer inspection, the bases of her lashes were caked in debris and collarettes, which got me thinking there must be a better way for our patients to look their best without negatively impa
Detecting the presence and severity of dry eye (DED) symptoms is important in the diagnosis and management of ocular surface diseases1. With escalation in the use of digital devices and myopia control interventions in school-aged children, the measurement of ocular surface comfort has become of grea
